PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Hearing Loss 30,622 Disease Disease Vertigo 10,084 1,734 0.10 -0.88 0.17 0.76
CCL19 658 Target Target CXCL16 341 13 0.03 -0.97 0.04 0.76
Endometriosis 16,342 Disease Disease Dysmenorrhea 3,263 654 0.09 -0.88 0.20 0.76
Alteplase (Activase)- FDA 112 Drug Drug Alprostadil (Prostin VR Pediatric)- FDA 26 1 0.02 -0.98 0.04 0.76
Activase (Alteplase)- FDA 112 Drug Drug Alprostadil (Prostin VR Pediatric)- FDA 26 1 0.02 -0.98 0.04 0.76
Acetic Acid (Acetic Acid)- FDA 168 Drug Drug Amaryl (Glimepiride)- FDA 7 1 0.03 -0.92 0.14 0.76
AMY2B 21 Target Target APOA2 118 1 0.02 -0.97 0.05 0.76
Adenosine A3 Receptor 164 Target Target Adenosine A1 Receptor 1,432 23 0.05 -0.92 0.14 0.76
CCL3 1,427 Target Target CXCL11 526 33 0.04 -0.96 0.06 0.76
Doxycycline Hyclate 145 Drug Drug Doxycycline 9,324 145 0.12 -0.08 1.00 0.76
4-1BB Receptor 20 Target Target CD137 474 4 0.04 -0.89 0.20 0.76
Glutathione Transferase Omega-1 14 Target Target Glutathione Peroxidase 3 132 1 0.02 -0.96 0.07 0.76
CA125 Antigen 78 Target Target BD2 76 1 0.01 -0.99 0.01 0.76
Allergies 10,264 Disease Disease Allergic Rhinitis 12,280 721 0.06 -0.94 0.07 0.76
CCL19 658 Target Target CCL3 1,427 36 0.04 -0.96 0.05 0.76
CCL18 256 Target Target CCL3 1,427 27 0.04 -0.94 0.11 0.76
Glutathione Peroxidase 3 132 Target Target Glutathione Peroxidase 6 13 1 0.02 -0.96 0.08 0.76
Phobias 1,578 Disease Disease Separation Anxiety 1,096 47 0.04 -0.96 0.04 0.76
CXCL16 341 Target Target CCL8 197 6 0.02 -0.98 0.03 0.76
Hepatitis 163,842 Disease Disease Liver Disease 49,817 15,950 0.18 -0.78 0.32 0.77
CCL19 658 Target Target CCL5 2,002 52 0.05 -0.95 0.08 0.77
AMBP 160 Target Target A1M 59 2 0.02 -0.98 0.03 0.77
Allergies 10,264 Disease Disease Eczema 12,327 748 0.07 -0.93 0.07 0.77
CD22 1,591 Target Target CD72 198 29 0.05 -0.92 0.15 0.77
Snoring 4,669 Disease Disease Sleep Disorders 6,847 331 0.06 -0.94 0.07 0.77
APOA2 118 Target Target APOC1 126 2 0.02 -0.98 0.02 0.77
CXCL16 341 Target Target CCL7 274 7 0.02 -0.98 0.03 0.77
FABP1 90 Target Target Carbonic Anhydrase 3 36 1 0.02 -0.98 0.03 0.77
Glutaredoxin-1 142 Target Target Glutathione S-Transferase Mu 2 8 1 0.03 -0.93 0.12 0.77
Aurora Kinase A 196 Target Target AURKC 26 2 0.03 -0.96 0.08 0.77
Nausea 42,627 Disease Disease Diarrhea 51,986 4,978 0.11 -0.89 0.12 0.77
Aurora Kinase A 196 Target Target Aurora A kinase 318 6 0.02 -0.98 0.03 0.77
Social Anxiety 3,287 Disease Disease Panic Disorder 7,455 330 0.07 -0.93 0.10 0.77
CCL7 274 Target Target CXCL11 526 11 0.03 -0.97 0.04 0.77
A1M 59 Target Target B2M 677 9 0.05 -0.91 0.15 0.77
EPHA4 357 Target Target EPHB4 329 8 0.02 -0.98 0.02 0.77
Accolate (Zafirlukast)- FDA 4 Drug Drug Acetic Acid (Acetic Acid)- FDA 168 1 0.04 -0.86 0.25 0.77
Atazanavir Sulfate (Reyataz)- FDA 40 Drug Drug Acetic Acid (Acetic Acid)- FDA 168 2 0.02 -0.97 0.05 0.77
CXCL16 341 Target Target CXCL3 145 6 0.03 -0.97 0.04 0.77
Abilify (Aripiprazole)- FDA 71 Drug Drug Acetaminophen (Tylenol)- FDA 69 1 0.01 -0.99 0.01 0.77
Acetaminophen (Tylenol)- FDA 69 Drug Drug Aripiprazole (Abilify)- FDA 71 1 0.01 -0.99 0.01 0.77
CCL18 256 Target Target CXCL11 526 11 0.03 -0.97 0.04 0.77
CCL7 274 Target Target CXCL10 2,386 51 0.06 -0.89 0.19 0.77
Fracture 111,575 Disease Disease Osteoporosis 46,215 11,132 0.16 -0.83 0.24 0.77
Endometriosis 16,342 Disease Disease Infertility 35,448 2,590 0.11 -0.88 0.16 0.77
CCL7 274 Target Target CXCL7 76 4 0.03 -0.97 0.05 0.77
Eotaxin 2,457 Target Target Eotaxin-3/CCL26 26 26 0.10 -0.19 1.00 0.77
CXCL16 341 Target Target CXCL7 76 5 0.03 -0.96 0.07 0.77
CCL18 256 Target Target CCL8 197 5 0.02 -0.98 0.03 0.77
Diabetic Nephropathy 12,496 Disease Disease Proteinuria 28,803 1,957 0.10 -0.89 0.16 0.77